Stay updated on MGL-3196 in NASH Patients: Clinical Trial
Sign up to get notified when there's something new on the MGL-3196 in NASH Patients: Clinical Trial page.

Latest updates to the MGL-3196 in NASH Patients: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedResults have been posted for the completed Phase 2 study of MGL-3196 (NCT02912260); the page now reflects updated objectives, outcomes, and supporting documentation, including the study status.SummaryDifference9%

- Check15 days agoChange DetectedThe Locations section has been updated. Location listings by state have been modified, and related topics such as Non-alcoholic fatty liver disease and MedlinePlus Genetics have been added.SummaryDifference2%

- Check36 days agoChange DetectedThe page now shows revision: v3.3.2, and has removed the 'Non-alcoholic fatty liver disease' topic and related topics such as 'MedlinePlus Genetics' (including the earlier 'Revision: v3.3.1'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedPublications section updated with minor edits: added Non-alcoholic fatty liver disease and MedlinePlus Genetics topics, and revised the note about PubMed-listed publications (v3.3.1 update from v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check51 days agoChange DetectedThe funding-status notice was removed from the page; the core study details and location information remain unchanged.SummaryDifference0.3%

- Check58 days agoChange DetectedRemoved related-topic links for 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' from the page.SummaryDifference0.1%

Stay in the know with updates to MGL-3196 in NASH Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGL-3196 in NASH Patients: Clinical Trial page.